New study provides insights into the safety of novel therapies for pulmonary embolism

A large, modern real-world analysis published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), provides vital insights into the safety of novel therapies including ultrasound-assisted catheter-directed thrombolysis (USCDT) and mechanical thrombectomy (MT) that have been developed to address the increased morbidity and mortality of elevated risk pulmonary embolism (PE). Findings were presented today at TCT 2023.

SPLIT program: Stratified care for enhanced outcomes in low back pain management

Low back pain, or LBP, challenges health systems worldwide. To mitigate persistent disabling LBP, the implementation of a stratified approach in primary care has been

May 29, 2024

Curaleaf Q1 Revenue Falls 2% Sequentially

Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million

May 18, 2023

Colorado Parks and Wildlife updates rules to allow ranchers to kill wolves that are attacking “working dogs” – The Cannabist

Colorado Parks and Wildlife has updated its rules to allow ranchers to kill wolves that are actively attacking “working dogs.” The post Colorado Parks and

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.